DEF201
DEF201 helps the host combat viral infections by using constitutively produced in situ human interferon protein; a proven broad spectrum antiviral with significant clinical success. DEF201 is composed of a replication defective Adenovirus vector which encodes the gene for the interferon alpha protein. Applied as a gentle nasal mist, DEF201 enters the cells lining your nose stimulate the host interferon system. In all the infectious viruses tested to date, only a single administration of intranasal DEF201, is required to provide sustained survival benefit in animal models.
Availability: In Development
| Manufacturer |
| Defyrus, Inc. |
| Product Name |
| DEF201 |
| Detection Category |
| Biological |
| Detection Method |
| Medical Countermeasure; |
| Application |
| Personal Protective Equipment; |
| Equipment Type |
| PPE |
| Product Synopsis |
| DEF201 helps the host combat viral infections by using constitutively produced in situ human interferon protein; a proven broad spectrum antiviral with significant clinical success. DEF201 is composed of a replication defective Adenovirus vector which encodes the gene for the interferon alpha protein. Applied as a gentle nasal mist, DEF201 enters the cells lining your nose stimulate the host interferon system. In all the infectious viruses tested to date, only a single administration of intranasal DEF201, is required to provide sustained survival benefit in animal models. |
| Availability |
| In Development |
| Technology Readiness Level (TRL) |
| 7 |
| User Feedback Sources |
| Indifferent/No user feedback |
| Transportability |
| Pocket Size |
| Live Agent Tested |
| Yes |
| Operating Time |
| Immediate post-exposure use |
| Training Required |
| <1 day training |
